A new slow-release drug delivery system, TAR-200, has been found highly effective in treating high-risk non-muscle-invasive bladder cancer. The treatment eliminated tumors in 82% of patients, with the majority disappearing after just three months and nearly half remaining cancer-free a year later. Researchers say this breakthrough therapy offers improved outcomes and saved lives for those previously resistant to traditional treatments.
Source: https://news.keckmedicine.org/new-treatment-eliminates-bladder-cancer-in-82-of-patients